Journal
BRIEFINGS IN FUNCTIONAL GENOMICS
Volume 18, Issue 2, Pages 107-112Publisher
OXFORD UNIV PRESS
DOI: 10.1093/bfgp/ely019
Keywords
gastric cancer; immune checkpoint inhibitor; immunogenomics; biomarkers
Funding
- Item of national natural science foundation [81472714]
Ask authors/readers for more resources
Gastric cancer remains the second most common cause of cancer-related death worldwide. Because of the poor prognosis of late-stage gastric cancer patients, it is imperative to develop new strategies to improve the survival rate of this disease. Currently, immunotherapy is considered as an innovative approach for cancers such as lung cancer, gastric cancer and breast cancer. In fact, previous works have revealed promising results in this field. With further understanding of immunogenomics of gastric cancer, new immune checkpoint regulators could become more important. In addition, whole-genome sequencing and genome editing provide us with more information on the heterogeneity of gastric cancer, showing helpful tools to identify new predictive biomarkers and to achieve personalized treatment. Further research and better understanding of the functions of immune system will enhance immunotherapy treatment in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available